ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1505

Blue-collar Workers with Psoriatic Arthritis: Disease Activity, Work Disability and Response to Biologics

Nina Colla1, Julia-Tatjana Maul2, Burkhard Moeller3, Michael Nissen4, Nikhil Yawalkar5, Eleftherios Papagiannoulis6, Oliver Distler1, Adrian Ciurea7 and Raphael Micheroli8, 1Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 2Department of Dermatology and Venereology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 3Inselspital - University Hospital Bern, Bern, Switzerland, 4Hopitaux Universitaires de Genève, Geneva, Switzerland, 5Department of Dermatology, University Hospital Inselspital Bern, Bern, Switzerland, 6Statistics Group, SCQM Foundation, Zurich, Switzerland., Zürich, 7University Hospital Zurich, Zürich, Switzerland, 8University Hospital Zurich, Department of Rheumatology, Zürich, Switzerland

Meeting: ACR Convergence 2022

Keywords: Disability, Disease Activity, Psoriatic arthritis, socioeconomic factors, TNF-blocking Antibody

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Biomechanical stress is a possible trigger of inflammation in psoriatic arthritis (PsA). The influence of physically demanding occupations on this potential association has not yet been investigated.

The aim of this study was to compare PsA patients who perform manual work (blue-collar (BCol) workers) with patients having more sedentary jobs (white-collar (WCol) workers) in terms of work disability, disease activity, and biologic response / retention rate.

Methods: PsA patients from the Swiss Clinical Quality Management cohort were included if they had available information on occupation and work disability, started a new biological treatment, and if baseline and follow-up (12 months ± 90 days) data on disease activity were available. Patients working in jobs associated with transportation, manufacturing or agriculture were classified as BCol, whereas patients working in less physically demanding jobs (office-worker, homemaker, teacher, etc.) were classified as WCol. Baseline characteristics were compared using Fisher’s exact for categorical and Kruskal-Wilcoxon test for continuous variables.

For longitudinal analysis, patients with more than 4 weeks work disability were excluded. Generalized estimating equation (GEE) models were used to examine the proportion of patients who achieved DAS28-CRP remission at 1 year. The retention rate was assessed using Kaplan-Meier survival curves and multiple-adjusted Cox proportional hazard regression. The following potential confounders were included in the models: disease duration, baseline disease activity, sex, BMI, type and line of biologic treatment and csDMARD co-therapy.

Results: 564 patients were included (29% BCol and 71% WCol worker). Baseline characteristics are shown in Table 1. At baseline, BCol workers were more likely to be male and had a higher rate of any work disability. Disease activity as well as patient reported outcomes were comparable. Occupation showed no effect on the proportion of patients achieving DAS28-CRP remission at one year in the GEE analysis (Table 2). Female sex and BMI > 30 kg/m2 were significantly associated with a lower remission rate in adjusted GEE analysis. Kaplan-Meier plots showed significantly longer biologic retention in BCol (mean retention duration 3.15 vs. 2.14 years in BCol and WCol, respectively). The adjusted retention analysis could not confirm this result, while the association remained for the female sex (Figure 1).

Conclusion: Compared with WCol workers, BCol workers with PsA had similar disease burden and response rates to biologics among those who continued to work. A very high percentage of BCol patients reported any work disability, which influences the true impact of work on PsA. However, work disability must be actively addressed in daily clinical practice, as employment is one of the most fundamental social determinants of health.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: N. Colla, None; J. Maul, None; B. Moeller, None; M. Nissen, AbbVie/Abbott, Pfizer, Amgen, Novartis, Janssen; N. Yawalkar, None; E. Papagiannoulis, None; O. Distler, AbbVie/Abbott, Amgen, GlaxoSmithKlein(GSK), Novartis, Roche, UCB, Kymera, Mitsubishi Tanabe, Boehringer Ingelheim, 4P-Pharma, Acceleron, Alcimed, Altavant Sciences, AnaMar, Arxx, AstraZeneca, Blade Therapeutics, Bayer, Corbus Pharmaceuticals, CSL Behring, Galapagos, Glenmark, Horizon, Inventiva, Lupin, Miltenyi Biotec, Merck/MSD, Prometheus Biosciences, Redx Pharma, Roivant, Sanofi, Topadur, Pfizer, Janssen, Medscape, Patent issued “mir-29 for the treatment of systemic sclerosis” (US8247389, EP2331143), FOREUM Foundation, ERS/EULAR Guidelines, EUSTAR, SCQM (Swiss Clinical Quality Management in Rheumatic Diseases), Swiss Academy of Medical Sciences (SAMW), Hartmann Müller Foundation; A. Ciurea, AbbVie, Novartis, Merck/MSD; R. Micheroli, None.

To cite this abstract in AMA style:

Colla N, Maul J, Moeller B, Nissen M, Yawalkar N, Papagiannoulis E, Distler O, Ciurea A, Micheroli R. Blue-collar Workers with Psoriatic Arthritis: Disease Activity, Work Disability and Response to Biologics [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/blue-collar-workers-with-psoriatic-arthritis-disease-activity-work-disability-and-response-to-biologics/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/blue-collar-workers-with-psoriatic-arthritis-disease-activity-work-disability-and-response-to-biologics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology